Company news

Cyclerion Therapeutics, Inc. news in 2019

Cyclerion Therapeutics, Inc.'s news releases, calls and decks from 2019, newest first.

Cyclerion Therapeutics Announces Topline Phase 2 Results for sGC Stimulator Praliciguat in Heart Failure with Preserved Ejection Fraction (HFpEF)

October 29, 2019

Cyclerion Therapeutics Announces Praliciguat Topline Phase 2 Results in Diabetic Nephropathy

October 29, 2019

Decks in 2019

Corporate Update (October 2019)
Corporate update · 17 slides · Oct 30, 2019